In partnership with the CommonSpirit Health network, the NeuroScience Innovation Foundation has plans to conduct studies in cost-effectiveness and cost benefit analysis for various therapies that address neurology disorders, especially ischemic stroke. The Foundation team will be led by a healthcare economist. Additional components of these investigations include an ambitious program of data integration between patient clinical records and financial cost accounting. The latter scope of work will be directed by Ruchir Shah, of Memorial CHI and CommonSpirit Health Network as well as industry partners.